Platelet News and Research

RSS

Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots

By combining a quantum dot with a novel carrier of the magnetic resonance imaging (MRI) agent gadolinium, a team of investigators at the University of Maastricht, in The Netherlands, has developed a nanoparticle that can spot apoptosis, or programmed cell death, using both MRI and fluorescence imaging.

8 Jan 2007

A chocolate or two a day, just what the doctor ordered!

A recent study has news that chocolate lovers will be overjoyed to hear, it seems that chocolate is good for the heart!

16 Nov 2006

Novel drug boosts platelets in ITP

Attacking a platelet-depleting autoimmune disease in a whole new way, an experimental drug is helping patients with immune thrombocytopenic purpura (ITP) once again produce healthy amounts of platelets -- with no major side effects.

14 Nov 2006

DIY cure for tennis elbow

Scientists in the United States have come up with a cure for tennis elbow by using the sufferers own blood.

25 Oct 2006

New biologic treatment for tennis elbow

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine.

23 Oct 2006

NicOx announces EMEA approval of Naproxcinod study plan

NicOx S.A today announced that it has received scientific advice on its proposed phase 3 clinical plan for naproxcinod (HCT 3012) from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA).

17 Oct 2006

Chikungunya adds to Dengue scare in India

The situation in the Indian city of Delhi, which is battling to control an outgreak of dengue fever now approaching epidemic proportions, has been exacerbated by an outbreak of another mosquito bourne disease, Chikungunya.

10 Oct 2006

A pill a day gives renewed hope for breast cancer victims

A new breast cancer 'wonder drug' could be available to British women within a matter of months.

9 Oct 2006

FDA approves Noxafil (posaconazole) to prevent invasive fungal infections

The U.S. Food and Drug Administration has approved Noxafil (posaconazole) to prevent fungal infections caused by certain molds and yeast-like fungus called Aspergillus and Candida.

19 Sep 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Colchicine delays development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis

Colchicine, an anti-inflammatory drug most often used to treat gout, prevented liver cancer in patients with hepatitis virus-related end-stage liver disease, according to a new study.

11 Sep 2006

Aspirin resistance: Fact or fable?

Coronary heart disease is the single leading cause of death in the Western world. Aspirin is a fundamental part of the prevention and treatment of coronary heart disease and is used by millions of patients worldwide.

5 Sep 2006

Simple bedside test may identify heart attack risk

The reason behind why patients who are on aspirin still have heart attacks is an important topic in cardiovascular disease.

5 Sep 2006

How effective is continued Plavix therapy in patients undergoing a repeat stent procedure?

Clopidogrel (Plavix) is used worldwide in millions of patients after placement of coronary artery stents. Sales of the drug exceed 5 billion US dollars.

5 Sep 2006

New cell-based targets for treating autoimmune inflammatory diseases

Patients with systemic autoimmune diseases such as lupus and rheumatoid arthritis (RA) often suffer loss of kidney function.

31 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006